The new treatments provide hope to the estimated 37 million people in the U.S. who suffer from migraines, predominantly women. The neurological disorder is characterized by intense, painful headaches, often accompanied by other symptoms, such as sensitivity to light and noise, and nausea.

Until now migraine patients have largely had to take drugs created to treat other diseases, such as epilepsy and high blood pressure. “What is coming is a complete change in the way we will treat migraine,” says Stewart Tepper, a neurology professor at the Geisel School of Medicine at Dartmouth.

https://www.wsj.com/articles/new-migraine-drugs-offer-hope-to-sufferers-1526658140